Clopidogrel Monotherapy in Patients With High Bleeding Risk

NCT05223335 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Bleeding Complications

Interventions

DRUG: Clopidogrel
DRUG: Prasugrel
DRUG: Tricagrelor

Sponsor

Mayo Clinic